Clinical relevance

Gene Type Therapy
BCL2 therapeutic target venetoclax
BTK therapeutic target ibrutinib
CD79B therapeutic target Polatuzumab vedotin
EZH2 therapeutic target tazemetostat
XPO1 therapeutic target selinexor

References